Lykos Therapeutics recently voiced its dissatisfaction with the Final Evidence Report issued by the Institute for Clinical and Economic Review (ICER) concerning its MDMA Assisted
Schizophrenia, which affects up to 1% of the population, is a neuropsychiatric disorder characterized by multiple symptoms.
The University of Colorado Denver has taken a groundbreaking step with the establishment of the CU Denver Center for Psychedelic Research. This innovative center aims
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in
Drugs that selectively kill senescent cells may benefit otherwise healthy older women but are not a “one-size-fits-all” remedy, Mayo Clinic researchers have found.
The correct functioning of cells relies heavily on the ability to finely control gene expression, a complex process by which the information contained in DNA
WASHINGTON — The Supreme Court took up an e-cigarette case Tuesday, weighing Food and Drug Administration decisions blocking the marketing of sweet flavored products amid a
On 30 June 2024, at the tenth Congress of the European Academy of Neurology (EAN) 2024, during an e-presentation session on the topic of ‘Headaches’,
What You Should Know: – Hummingbird Healthcare Inc., a tech-driven healthcare services company raises $10M in Series A funding led by UCHealth, a leading Colorado-based
Rise and shine, another busy day is on the way. However, this is also shaping up as a beautiful day as well, given the clear